BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 37205253)

  • 1. α-Synuclein Seed Amplification Assays in the Diagnosis of Synucleinopathies Using Cerebrospinal Fluid-A Systematic Review and Meta-Analysis.
    Grossauer A; Hemicker G; Krismer F; Peball M; Djamshidian A; Poewe W; Seppi K; Heim B
    Mov Disord Clin Pract; 2023 May; 10(5):737-747. PubMed ID: 37205253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of α-synuclein seeding amplification assays in α-synucleinopathies: A systematic review and meta-analysis.
    Yoo D; Bang JI; Ahn C; Nyaga VN; Kim YE; Kang MJ; Ahn TB
    Parkinsonism Relat Disord; 2022 Nov; 104():99-109. PubMed ID: 36289019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological α-synuclein detected by real-time quaking-induced conversion in synucleinopathies.
    Huang J; Yuan X; Chen L; Hu B; Wang H; Wang Y; Huang W
    Exp Gerontol; 2024 Mar; 187():112366. PubMed ID: 38280659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RT-QuIC and Related Assays for Detecting and Quantifying Prion-like Pathological Seeds of α-Synuclein.
    Srivastava A; Alam P; Caughey B
    Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Synuclein Seeding Assay Using RT-QuIC.
    Okuzumi A; Hatano T; Fukuhara T; Ueno S; Nukina N; Imai Y; Hattori N
    Methods Mol Biol; 2021; 2322():3-16. PubMed ID: 34043187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are We Ready for Detecting α-Synuclein Prone to Aggregation in Patients? The Case of "Protein-Misfolding Cyclic Amplification" and "Real-Time Quaking-Induced Conversion" as Diagnostic Tools.
    Paciotti S; Bellomo G; Gatticchi L; Parnetti L
    Front Neurol; 2018; 9():415. PubMed ID: 29928254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies.
    Poggiolini I; Gupta V; Lawton M; Lee S; El-Turabi A; Querejeta-Coma A; Trenkwalder C; Sixel-Döring F; Foubert-Samier A; Pavy-Le Traon A; Plazzi G; Biscarini F; Montplaisir J; Gagnon JF; Postuma RB; Antelmi E; Meissner WG; Mollenhauer B; Ben-Shlomo Y; Hu MT; Parkkinen L
    Brain; 2022 Apr; 145(2):584-595. PubMed ID: 34894214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasensitive Detection of Aggregated α-Synuclein in Glial Cells, Human Cerebrospinal Fluid, and Brain Tissue Using the RT-QuIC Assay: New High-Throughput Neuroimmune Biomarker Assay for Parkinsonian Disorders.
    Manne S; Kondru N; Hepker M; Jin H; Anantharam V; Lewis M; Huang X; Kanthasamy A; Kanthasamy AG
    J Neuroimmune Pharmacol; 2019 Sep; 14(3):423-435. PubMed ID: 30706414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid.
    Concha-Marambio L; Pritzkow S; Shahnawaz M; Farris CM; Soto C
    Nat Protoc; 2023 Apr; 18(4):1179-1196. PubMed ID: 36653527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid and ultra-sensitive quantitation of disease-associated α-synuclein seeds in brain and cerebrospinal fluid by αSyn RT-QuIC.
    Groveman BR; Orrù CD; Hughson AG; Raymond LD; Zanusso G; Ghetti B; Campbell KJ; Safar J; Galasko D; Caughey B
    Acta Neuropathol Commun; 2018 Feb; 6(1):7. PubMed ID: 29422107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden.
    Bentivenga GM; Mammana A; Baiardi S; Rossi M; Ticca A; Magliocchetti F; Mastrangelo A; Poleggi A; Ladogana A; Capellari S; Parchi P
    Acta Neuropathol; 2024 Jan; 147(1):18. PubMed ID: 38240849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson's disease.
    Russo MJ; Orru CD; Concha-Marambio L; Giaisi S; Groveman BR; Farris CM; Holguin B; Hughson AG; LaFontant DE; Caspell-Garcia C; Coffey CS; Mollon J; Hutten SJ; Merchant K; Heym RG; Soto C; Caughey B; Kang UJ
    Acta Neuropathol Commun; 2021 Nov; 9(1):179. PubMed ID: 34742348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study.
    Iranzo A; Fairfoul G; Ayudhaya ACN; Serradell M; Gelpi E; Vilaseca I; Sanchez-Valle R; Gaig C; Santamaria J; Tolosa E; Riha RL; Green AJE
    Lancet Neurol; 2021 Mar; 20(3):203-212. PubMed ID: 33609478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson's disease and dementia with Lewy bodies.
    Bargar C; Wang W; Gunzler SA; LeFevre A; Wang Z; Lerner AJ; Singh N; Tatsuoka C; Appleby B; Zhu X; Xu R; Haroutunian V; Zou WQ; Ma J; Chen SG
    Acta Neuropathol Commun; 2021 Apr; 9(1):62. PubMed ID: 33827706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies.
    Rossi M; Candelise N; Baiardi S; Capellari S; Giannini G; Orrù CD; Antelmi E; Mammana A; Hughson AG; Calandra-Buonaura G; Ladogana A; Plazzi G; Cortelli P; Caughey B; Parchi P
    Acta Neuropathol; 2020 Jul; 140(1):49-62. PubMed ID: 32342188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease.
    Hall S; Orrù CD; Serrano GE; Galasko D; Hughson AG; Groveman BR; Adler CH; Beach TG; Caughey B; Hansson O
    Acta Neuropathol Commun; 2022 Jun; 10(1):90. PubMed ID: 35733234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid.
    Shahnawaz M; Tokuda T; Waragai M; Mendez N; Ishii R; Trenkwalder C; Mollenhauer B; Soto C
    JAMA Neurol; 2017 Feb; 74(2):163-172. PubMed ID: 27918765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The promise of amplification assays for accurate early detection of α-synucleinopathies: A review.
    Kurapova R; Chouliaras L; O'Brien JT
    Exp Gerontol; 2022 Aug; 165():111842. PubMed ID: 35623540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of Method for the Determination of Aggregated α-Synuclein in DLB Patient Using RT-QuIC Assay.
    Park SJ; Lee YJ; Park JH; Jin HT; Choi MJ; Jung CG; Akatsu H; Choi EK; Kim YS
    Protein Pept Lett; 2021; 28(1):115-120. PubMed ID: 32310037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin α-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson Disease.
    Wang Z; Becker K; Donadio V; Siedlak S; Yuan J; Rezaee M; Incensi A; Kuzkina A; Orrú CD; Tatsuoka C; Liguori R; Gunzler SA; Caughey B; Jimenez-Capdeville ME; Zhu X; Doppler K; Cui L; Chen SG; Ma J; Zou WQ
    JAMA Neurol; 2020 Sep; 78(1):1-11. PubMed ID: 32986090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.